Redefining Noninvasive 

Ocular Therapeutics​

Publications and Presentations on Aciont's Research

Recent Publications

An ongoing series of informational entries

Passive Drug Delivery with Ocular Application Delivery System and Clearance Effect


David Miller and Kevin Li and colleagues discuss the effects of intraocular clearance using a topical ocular drug delivery system. 

DSP-Visulex in Pan Uveitis Efficacy Model

November, 2017

Papangkorn and colleagues discuss efficacy in a pan uveitis (ocular inflammation induction) model in rabbit with respect to a wide variety of treatment modalities (treatment time duration and concentration/formulation) with DSP-Visulex.

DSP-Visulex Pharmacokinetic and Safety Evaluation

February, 2018

Papangkorn and colleagues discuss drug transport kinetics and safety with respect to a wide variety of treatment modalities (treatment time duration and concentration/formulation) with DSP-Visulex.

Archived Research Presentations

An ongoing series of informational entries

Transscleral Iontophoretic Delivery of a Macromolecule into the Rabbit Eye

By John Higuchi; Kongnara Papangkorn; Sarah Molokhia; Donald Mix; Charlotte Butler; Prasoona Karra; Balbir Brar; S. Kevin Li; William I. Higuchi

David Miller and Kevin Li and colleagues discuss the effects of intraocular clearance using a topical ocular drug delivery system. 

Transscleral Iontophoretic Delivery of Avastin® In Vivo: Drug Distribution and Safety Aspects

By Sarah A. Molokhia; Kongnara Papangkorn; Donald Mix; Charlotte Butler; Prasoona Karra; John Higuchi; Balbir Brar; S. Kevin Li; William I. Higuchi


Pharmacodynamics of Noninvasive Electroosmotic Delivery of Bevacizumab for the Treatment of Choroidal Neovascularization in Rabbits

By Sarah Molokhia; Kongnara Papangkorn; Charlotte Butler; Michael Burr; John Higuchi; Balbir Brar; Balamurali Ambati; William Higuchi


Research Presentations

An ongoing series of informational entries

A Sustained Release System of Dexamethasone Sodium Phosphate With Calcium Ion Delivered From a Visulex Passive Lens Device

By J. W. Higuchi; W. I. Higuchi; K. Papangkorn; S. K. Li; R. P. Kochambilli; A. L. Tuitupou; D. C. Mix, Jr.

Papangkorn and colleagues discuss efficacy in a pan uveitis (ocular inflammation induction) model in rabbit with respect to a wide variety of treatment modalities (treatment time duration and concentration/formulation) with DSP-Visulex.

Transscleral Passive Delivery of Rapamycin in Rabbit Using a Visulex Topical Application Device

By K. Papangkorn; D. C. Mix, Jr.; K. M. Gupta; J. W. Higuchi; B. Brar; S. K. Li; W. I. Higuchi

Papangkorn and colleagues discuss drug transport kinetics and safety with respect to a wide variety of treatment modalities (treatment time duration and concentration/formulation) with DSP-Visulex.

© 2018 Aciont Inc.